PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling

Shi-Lin Tang1, Wu-Jun Chen, Kai Yin

  • 1Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Life Science Research Center, University of South China, Hengyang, Hunan 421001, China.

Atherosclerosis
|April 17, 2012
PubMed

Insights

Pregnancy-associated plasma protein-A (PAPP-A) reduces cholesterol efflux by down-regulating LXRα and key cholesterol transporters (ABCA1, ABCG1, SR-B1) via the IGF-1/PI3-K/Akt pathway, contributing to atherosclerosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Pregnancy-associated plasma protein-A (PAPP-A) influences atherosclerosis by regulating insulin-like growth factor-1 (IGF-1).
  • IGF-1 signaling, via PI3-K/Akt, affects cholesterol efflux and nitric oxide formation.
  • The PI3-K/Akt pathway can decrease cholesterol efflux by reducing ABCA1 and SR-B1 expression.

Purpose of the Study:

  • To investigate PAPP-A's role in regulating liver X receptor alpha (LXRα) and cholesterol transporter expression (ABCA1, ABCG1, SR-B1).
  • To determine if the IGF-1-mediated signaling pathway (IGF/PI3-K/Akt) is involved in PAPP-A's effects.
  • To elucidate the mechanism by which PAPP-A contributes to the pathogenesis of atherosclerosis.

Main Methods:

  • Dose- and time-dependent experiments assessing PAPP-A's effect on ABCA1, ABCG1, and SR-B1 expression at transcriptional and translational levels.
  • Measurement of cellular cholesterol content and cholesterol efflux following PAPP-A treatment.
  • Investigation of LXRα regulation and the involvement of the IGF-1/PI3-K/Akt pathway using specific inhibitors and siRNA.
  • Analysis of PAPP-A's impact on the MAPK cascade.

Main Results:

  • PAPP-A significantly decreased ABCA1, ABCG1, and SR-B1 expression in a dose- and time-dependent manner.
  • PAPP-A treatment increased cellular cholesterol content and decreased cholesterol efflux.
  • PAPP-A down-regulated LXRα expression, which was partially rescued by LXRα agonist activation.
  • The IGF-1/PI3-K/Akt pathway, but not the MAPK cascade, was involved in PAPP-A-induced downregulation of LXRα, ABCA1, ABCG1, and SR-B1.

Conclusions:

  • PAPP-A down-regulates LXRα expression through the IGF-1/PI3-K/Akt signaling pathway.
  • This down-regulation leads to decreased expression of ABCA1, ABCG1, and SR-B1, impairing cholesterol efflux in macrophage-derived foam cells.
  • The study elucidates a key mechanism for PAPP-A's contribution to atherosclerosis pathogenesis.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...